○Kota Shigematsu1, Mariko Fukuta1, Takuya Okada1, Naoya Ichihara1, Haruka Mano1, Yoshikazu Hattori1, Vladimir Sychrovsky2, Yoshiyuki Tanaka1 (1. Fac. Pharm. Sci., Tokushima Bunri Univ., 2. Acad. Sci. Czech Republic)
Session information
Poster Presentation
(B) Radiochemistry
[28P01] 生体物質・生体高分子・その他
Sun. Mar 28, 2021 9:00 AM - 6:00 PM [Room P01] Poster Presentation (Online)
[28P01-099S] Activation mechanism of mu opioid receptor controlled by the conformational equilibrium
○Shun Kaneko1,2, Shunsuke Imai2, Nobuaki Asao1,2, Yutaka Kofuku1, Takumi Ueda1, Ichio Shimada2 (1. Grad. Sch. Pharm. Sci., The Univ. of Tokyo., 2. BDR, RIKEN)
○Yue Chen1, Dongqing Pan1, Hiroaki Kato1,2 (1. Grad. Sch. Pharm Sci., Kyoto Univ., 2. RIKEN SPring-8 Center)
[28P01-101] Structural analysis of ssPalm-cholesterol lipid nanoparticles using molecular simulation
Karen Ujiie1, Ruka Nishida1, Koji Okuwaki2, Yuji Mochizuki2, Hiroki Tanaka3, Hidetaka Akita3, Takayuki Furuishi1, ○Kaori Fukuzawa1, Etsuo Yonemochi1 (1. Hoshi Univ., 2. Rikkyo Univ., 3. Chiba Univ.)
[28P01-102S] Effects of amino acid mutations on phospholipid-amphipathic peptide nanofiber formation
○Tatsuya Kato1, Hiroyuki Nakao2, Keisuke Ikeda2, Minoru Nakano2 (1. Fac. of Pharm., Univ. of Toyama, 2. Grad. Sch. Med. Pharm. Sch., Univ. Toyama)
○Jun Kuwahara1, Kanami Nakamura1, Fumina Izukashi1 (1. Fac. Pharm. Sci., Doshisha Women's Univ.)
○Miki Ajima1, Yuya Ashizawa1, Takuya Nomura1, Yusuke Kuwana1, Mayu Kakeno1, Shunya Hirai1, Takashi Miura1 (1. Dept. Pharm. Sci., Int. Univ. Health and Welfare)
○Jiaqi Wang1, Atsushi Furukawa1, Rika Yamazaki1, Koyuki Hirayasu2,3, Tsuyoshi Kadomatsu4, Yuichi Oike4, Hirashi Arase2, Katsumi Maenaka1 (1. Pharm. Sci. Hokkaido Univ., 2. Res. Inst. Microbial Diseases, Osaka Univ., 3. Adv. Preventive. Med. Sci. Res. Center., Kanazawa Univ., 4. Med., Kumamoto Univ. )
○Hiroyuki Tsutsumi1, Tomonori Ohata1, Miho Yukawa1, Hirohito Ikeda1 (1. Fac. Pharm. Sci., Fukuoka Univ.)
○Norihiro Namba1, Hiroki Kono1, Takashi Ohgita1, Toshinori Shimanouchi2, Hiroyuki Saito1 (1. Kyoto Pharm. Univ., 2. Grad. Sch. Environmental and Life Science, Okayama Univ.)
○Miyu Nakano1, Takashi Ohgita1, Izumi Morita2, Hiroyuki Oyama2, Norihiro Kobayashi2, Hiroyuki Saito1 (1. Kyoto Pharm. Univ., 2. Kobe Pharm. Univ.)
○Riho Ninomiya1, Yuki Hattori1, Ruriko Suzuki1, Masahiko Tanaka1, Naohide Hirashima1 (1. Grad. Sch. Pharmaceut. Sci., Nagoya City Univ.)
○Kenta Morimoto1, Kosuke Noguchi2, Masamitsu Kanada3, Ikuhiko Nakase1,2 (1. College of Life, Environment, and Advanced Sciences, Osaka Prefecture University, 2. Graduate School of Science, Osaka Prefecture University, 3. Instituite for Quantitative Health Science and Engineering, Michigan State University)
○Yu Maeshiro1, Hiroyuki Nakao2, Keisuke Ikeda2, Minoru Nakano2 (1. Fac. of Pharm., Univ. of Toyama, 2. Grad. Sch. Med. Pharm. Sch., Univ. Toyama)
○Kentaro Uesugi1, Shosaku Motohara1, Takamitsu Okayama1, Takashi Mochizuki2, Akira Tokoyo1, Yukie Kasama1, Toshiyuki Onishi1 (1. TEIJIN PHARMA, 2. Medical Ultrasound Laboratory)